Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
Antiviral agents
Biosensor
Chloroquine
Coronavirus
SARS-CoV-2
Severe acute respiratory syndrome
Journal
International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
28
04
2020
revised:
23
05
2020
accepted:
06
06
2020
pubmed:
14
6
2020
medline:
22
8
2020
entrez:
14
6
2020
Statut:
ppublish
Résumé
The emergence and rapid spread of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a potentially fatal disease, is swiftly leading to public health crises worldwide. The origin of SARS-CoV-2 infection was first reported in people exposed to a seafood market in Wuhan City, China in December 2019. It has been suggested that the infection is likely to be of zoonotic origin and transmitted to humans through a not-yet-known intermediary. As of 22 May 2020, the World Health Organization reported that there were approximately 4,995,996 confirmed cases and 327,821 deaths. SARS-CoV-2 is transmitted via inhalation or direct contact with droplets from infected people. It has an incubation period ranging from 2 to ≥14 days. The rate of spread of SARS-CoV-2 is greater than that for severe acute respiratory syndrome coronavirus and Middle East respiratory coronavirus. The symptoms are similar to influenza (i.e. breathlessness, sore throat and fatigue) and infected cases are isolated and treated. Infection is mild in most cases, but in elderly (>50 years) patients and those with cardiac and respiratory disorders, it may progress to pneumonia, acute respiratory distress syndrome and multi-organ failure. People with strong immunity or those who have developed herd immunity are asymptomatic. The fatality rate ranges from 3% to 4%. Recommended methods for diagnosis of COVID-19 are molecular tests (e.g. polymerase chain reaction) on respiratory secretions, chest scan and common laboratory diagnosis. Currently, treatment is essentially supportive, and the role of antiviral agents is yet to be established as a vaccine is not yet available. This review will focus on epidemiology, symptoms, transmission, pathogenesis, ongoing available treatments and future perspectives of SARS-CoV-2.
Identifiants
pubmed: 32534188
pii: S0924-8579(20)30224-7
doi: 10.1016/j.ijantimicag.2020.106054
pmc: PMC7286265
pii:
doi:
Substances chimiques
Antiviral Agents
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106054Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Lancet Infect Dis. 2020 Apr;20(4):400-402
pubmed: 32113509
Anal Biochem. 2016 Dec 1;514:2-7
pubmed: 27615801
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188
pubmed: 32164085
Structure. 2016 Mar 1;24(3):401-11
pubmed: 26853940
Antiviral Res. 2020 Jun;178:104786
pubmed: 32251767
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
J Virol. 2013 Jul;87(14):7790-2
pubmed: 23678167
Lancet Respir Med. 2020 Jun;8(6):539-541
pubmed: 32304640
Lancet. 2020 May 9;395(10235):1517-1520
pubmed: 32311318
Anal Chim Acta. 2018 Oct 5;1026:1-7
pubmed: 29852984
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Drug Discov Ther. 2020;14(1):58-60
pubmed: 32147628
Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6
pubmed: 15616839
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Allergy. 2020 Jul;75(7):1742-1752
pubmed: 32239761
Eur J Clin Invest. 2020 Mar;50(3):e13209
pubmed: 32003000
Virol Sin. 2016 Aug;31(4):279-87
pubmed: 27405928
ACS Nano. 2020 May 26;14(5):5268-5277
pubmed: 32281785
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
BMC Res Notes. 2011 Oct 25;4:446
pubmed: 22026976
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):147-157
pubmed: 32391658
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
J Infect. 2020 Jul;81(1):e21-e23
pubmed: 32283143
ACS Cent Sci. 2020 Mar 25;6(3):315-331
pubmed: 32226821
PLoS Med. 2006 Sep;3(9):e343
pubmed: 16968120
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
N Engl J Med. 2020 Feb 27;382(9):872-874
pubmed: 31991079
Biosens Bioelectron. 2020 Sep 1;163:112274
pubmed: 32421627
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Int J Antimicrob Agents. 2020 May;55(5):105938
pubmed: 32171740
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
Lancet. 2020 Feb 15;395(10223):e30-e31
pubmed: 32032529
J Infect. 2020 Jul;81(1):e1-e5
pubmed: 32171872
J Clin Virol. 2001 Feb;20(3):137-40
pubmed: 11166662
Bioorg Med Chem. 2006 Apr 15;14(8):2552-8
pubmed: 16326106
J Infect Dis. 2015 Jan 1;211(1):80-90
pubmed: 25030060
Biosci Trends. 2020 Mar 16;14(1):69-71
pubmed: 31996494
Antiviral Res. 2013 Sep;99(3):301-6
pubmed: 23769930
Lancet. 2014 Feb 22;383(9918):723-35
pubmed: 23953767
Nat Rev Nephrol. 2011 Oct 18;7(12):718-29
pubmed: 22009248
Lancet Infect Dis. 2020 Oct;20(10):1118-1119
pubmed: 32311324
Mol Cancer Ther. 2016 Apr;15(4):560-73
pubmed: 26832790
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
PLoS Pathog. 2014 Nov 06;10(11):e1004502
pubmed: 25375324
ACS Nano. 2020 Apr 28;14(4):5135-5142
pubmed: 32293168
Biomed Pharmacother. 2020 Jan;121:109652
pubmed: 31734578
Thorax. 2004 Mar;59(3):252-6
pubmed: 14985565
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Sci Rep. 2016 Aug 08;6:31103
pubmed: 27499342
Int J Antimicrob Agents. 2007 Oct;30(4):297-308
pubmed: 17629679
N Engl J Med. 2004 Apr 22;350(17):1731-9
pubmed: 15102999
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Biochem J. 2012 May 1;443(3):851-6
pubmed: 22417684
Vaccine. 2017 Aug 16;35(35 Pt A):4470-4474
pubmed: 28633891
Lancet Infect Dis. 2013 Sep;13(9):752-61
pubmed: 23891402
FASEB J. 1997 Mar;11(4):248-55
pubmed: 9068613
Nat Rev Drug Discov. 2020 Mar;19(3):149-150
pubmed: 32127666
JAMA. 2003 Oct 1;290(13):1695-6
pubmed: 14519691
Clin Infect Dis. 2020 Nov 19;71(16):2089-2098
pubmed: 32361738
Science. 2003 Jun 13;300(5626):1763-7
pubmed: 12746549
Nature. 2018 Mar 28;555(7698):604-610
pubmed: 29595767
Med (N Y). 2020 Dec 18;1(1):105-113.e4
pubmed: 32838353
Environ Sci Technol. 2020 Apr 7;54(7):3730-3732
pubmed: 32202420
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Biochemistry. 2020 May 12;59(18):1769-1779
pubmed: 32293875
J Biomol Screen. 2011 Feb;16(2):192-200
pubmed: 21297106
Clin Chim Acta. 2007 Feb;376(1-2):114-20
pubmed: 16989795
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
Nat Biotechnol. 2020 May;38(5):523-532
pubmed: 32203293
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
Water Res. 2009 Apr;43(7):1893-8
pubmed: 19246070
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Emerg Infect Dis. 2004 Apr;10(4):581-6
pubmed: 15200845
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
J Biomol Struct Dyn. 2021 Jul;39(11):3842-3854
pubmed: 32431217
Biosens Bioelectron. 2015 May 15;67:532-9
pubmed: 25266252
Am J Respir Crit Care Med. 2020 Feb 15;201(4):P7-P8
pubmed: 32004066
Int J Antimicrob Agents. 2020 Apr;55(4):105932
pubmed: 32145363
Antivir Ther. 2018;23(7):617-622
pubmed: 29923831
Exp Biol Med (Maywood). 2009 Oct;234(10):1117-27
pubmed: 19546349
Virus Res. 2005 Dec;114(1-2):23-34
pubmed: 15992957
Curr Med Chem. 2020;27(27):4536-4541
pubmed: 32297571
J Med Virol. 2020 Apr;92(4):441-447
pubmed: 31994742
N Engl J Med. 2007 Oct 4;357(14):1450-1
pubmed: 17914053
Curr Med Chem. 2008;15(10):997-1005
pubmed: 18393857
Biol Chem. 2015 Dec;396(12):1357-67
pubmed: 26351913
Lancet. 2020 Mar 21;395(10228):949
pubmed: 32087125
Am J Infect Control. 2016 May 2;44(5 Suppl):e91-e100
pubmed: 27131142
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Nat Biotechnol. 2020 Apr;38(4):379-381
pubmed: 32205870
J Virol. 2001 Oct;75(19):9345-56
pubmed: 11533198
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Radiology. 2020 Apr;295(1):18
pubmed: 32003646
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Sci Rep. 2016 Mar 18;6:23138
pubmed: 26988202
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
BMJ. 2020 Mar 18;368:m1090
pubmed: 32188598